
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Premier Research, clinical research company, announced a new scholarship for rare disease patient advocates in partnership with
These initiatives reflect Premier Research's inclusive approach to the research and development of drugs and devices in which the voice of the patient is an essential part of the network of stakeholders searching for treatments and cures.
Read the full release






